Detailed answers about NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED, including incorporation, status, business activity, and accounts information.
When was NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED founded?
NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED was officially incorporated on 15 January 2001 and is registered under company number 04141489. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED?
NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED do?
NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED operates in the following sector: 94110 - Activities of business and employers membership organizations. This provides insight into the company's primary business activity and industry focus.
What is NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED's registered address?
The registered office address of NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED is MALLINSON HOUSE, 38-42 ST PETERS STREET, ST ALBANS, HERTS, AL1 3NP. This is the official address filed with Companies House for legal and statutory correspondence.
Is NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED financially stable?
The most recent accounts for NATIONAL PHARMACEUTICAL ASSOCIATION LIMITED were made up to 31 December 2024, filed as DORMANT. Next accounts are due by 30 September 2026.